Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Canaccord

View:

Post by 3burtc on Feb 18, 2021 12:42pm

Canaccord

Seeing Canaccords target price is $16.50, does the price go up dramatically before they resell the bought deal?

216

Comment

Comment by clubhouse19 on Feb 18, 2021 2:31pm

Why wouldn't they have a Target near 3 times their bought deal. Canaccord one of the least trustworthy of all baystreet Couln't be trusted one bit IMO>

161

Comment

Comment by 08KLR650 on Feb 18, 2021 2:49pm

It's all stock promotion now that they own 35 million shares, I don't like it because I believe in the company and science. It just feels slimy now.

106

Comment

Comment by crow27 on Feb 18, 2021 2:56pm

They don't own 35 million shares?? They just gave us 35 million dollars.

100

Comment

Comment by 08KLR650 on Feb 18, 2021 3:01pm

35 million dollars worth of shares, Better!!!

Comment

Comment by 3burtc on Feb 18, 2021 3:03pm

I didn't say they own 35 million shares, i said will they resell them @ $16.50, there price target? Do you know what a bought deal is?

Comment

Comment by NotBornLastNite on Feb 18, 2021 3:07pm

BOUGHT me a friggin head ache.

Comment

Comment by clubhouse19 on Feb 18, 2021 3:36pm

LOL Do you actually believe their BS...and think they will sell at 16.50/ The subscribers will have have already shorted this and made their money way before it ever reaches 16.50. They have already made their money

222

Comment

Comment by filmguyToronto on Feb 18, 2021 4:55pm

Unfortunately, this dilutes all of the shares we all own. So, it's a temporary drop. But, it will create more discussion and interest for Antibe. So, a good thing overall. From somehting I read earlier, they need something like $300 Million to complete the Phase 3 trials. They just received $100 million from the China Deal, plus an additonal $35Million from this deal. Moving to the OTC Market ...more

178

Comment

Comment by Marky1 on Feb 18, 2021 5:07pm

300M$ to complete P3....What are you smoking??

Comment

Comment by crow27 on Feb 18, 2021 5:22pm

You better stick to making films?????

103

Comment

Comment by MrMugsy on Feb 18, 2021 5:26pm

Filmguy ... the last number out of Dan's mouth was around $50M-$55M needed for P3. Also keep in mind that we had earmarked $5M from the last PP for the dose ranging portion of P3. It's a whole new ball game now - we are more and more in control of our destiny each day ... thankfully !!!!

213

Comment

Comment by RjM2018 on Feb 18, 2021 7:57pm

I don't know where you are getting your info. 1. Median Phase 3 trial cost is 19 million as per jama/nature publications. This trial isn't an overly large one with thousands and thousands of patients lasting years...https://cienp.org.br/wp-content/uploads/2018/11/How-much-do-phase-III-trials.pdf 2. They don't have a vet division...if you're talking about citigenix that's ...more

143

Comment

Antibe Therapeutics Inc(Pre-Merger)